Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Recs

0
Player Avatar TrackUltraLong (< 20) Submitted: 2/25/2013 3:06:24 AM : Outperform Start Price: $4.57 ENZN Score: -40.82

http://www.fool.com/investing/general/2013/02/19/3-stocks-near-52-week-lows-worth-buying-20.aspx

Report this Post Reply

Featured Broker Partners


Advertisement